65 Matching Annotations
  1. Last 7 days
    1. Andre, F., Booy, R., Bock, H., Clemens, J., Datta, S., John, T., Lee, B., Lolekha, S., Peltola, H., Ruff, T., Santosham, M., & Schmitt, H. (2008). Vaccination greatly reduces disease, disability, death and inequity worldwide. Bulletin of the World Health Organization, 86(2), 140–146. https://doi.org/10.2471/BLT.07.040089

  2. Apr 2021
  3. Mar 2021
    1. Opel, D. J., Heritage, J., Taylor, J. A., Mangione-Smith, R., Salas, H. S., DeVere, V., Zhou, C., & Robinson, J. D. (2013). The Architecture of Provider-Parent Vaccine Discussions at Health Supervision Visits. Pediatrics, 132(6), 1037–1046. https://doi.org/10.1542/peds.2013-2037

    1. Li, S., Sim, S.-C., Lee, L., Pollack, H. J., Wyatt, L. C., Trinh-Shevrin, C., Pong, P., & Kwon, S. C. (2017). Hepatitis B Screening and Vaccination Behaviors among a Community-based Sample of Chinese and Korean Americans in New York City. American Journal of Health Behavior, 41(2), 204–214. https://doi.org/10.5993/AJHB.41.2.12

  4. Feb 2021
    1. Andrew💙Croxford. (2020, December 3). NEW THREAD: possible development of anti-Syncytin responses after immunization with the SARS-CoV-2 spike protein-coding mRNA vaccines, based on a ‘homologous’ region shared between these proteins. [Tweet]. @andrew_croxford. https://twitter.com/andrew_croxford/status/1334593606196187136

  5. Jan 2021
  6. Sep 2020
  7. Jul 2020
  8. Jun 2020
  9. May 2020
  10. Feb 2020
    1. Annual immunization against influenza (for children and young people with diabetes over the age of 6 months).Immunization against pneumococcal infection (for children and young people with diabetes who need insulin or oral hypoglycaemic drugs).

      T1DM children

      • annual flu vaccine
      • pneumoccocal vaccine
    1. Routine pneumococcal vaccination

      Routine pneumococcal vaccine for:

      Infants - PCV13 - 2m,4m,12m

      Over 65 - PPV23 - one-off

    2. Risk factors

      People at increased risk of pneumococcal disease or complications include those with:

      • Asplenia or splenic dysfunction.
      • Chronic respiratory, heart, kidney, or liver disease.
      • Diabetes requiring insulin or oral hypoglycaemic drugs.
      • Immunosuppression due to a medical condition or treatment.
      • Cochlear implants.
      • Cerebrospinal fluid leaks (including leakage following trauma or major skull surgery).
      • Occupational risks (including welders). For more details, see the section on Risk factors.
    1. For people who are allergic to egg or have had a confirmed anaphylactic reaction to egg

      Contraindications

      • Egg allergy
      • Anaphylaxis
      • Acutely unwell
      • Children who are severely immunocompromised
      • Children with respiratory symptoms
    2. Clinical risk groups in people aged 6 months and older

      Influenza vaccine for >65s and specific risk groups

      • Asplenia or splenic dysfunction.
      • Chronic respiratory, heart, kidney, or liver disease.
      • Diabetes requiring insulin or oral hypoglycaemic drugs.
      • Immunosuppression due to a medical condition or treatment.
      • Chornic neurological disease
      • Pregnant women
      • Children aged 2 to 10 years (but not aged 11 years or older) on 31 August 2019.
      • People living in long-stay residential and nursing homes or other long-stay care facilities (not including prisons, young offender's institutions, or university halls of residence).
      • Close contacts of immunocompromised people, including carers (people who expect to share living accommodation on most days over the winter).
      • All healthcare and social care workers directly involved in patient care, including students, trainees, and volunteers working with patients.